The company specializes in discovering and developing a new class of drugs that target depression, anxiety, and gastrointestinal diseases, addressing unmet medical needs. Their therapeutics stimulate the central nervous system through the gut-brain axis, providing researchers and doctors with access to innovative treatment options.